HEADQUARTERS, Montpellier, France
Housing our World Business Development Activities, Finances, General administration, Reglementary Affairs, IP and Marketing Departments.
HOLDING, Zurich, Switzerland
Management of Medincell’s capital
BIOCHEMISTRY PLATFORM, Montpellier, France
High Technicality Platform managed by 20 year’s experience researchers who invent, synthesize, characterize, formulate and promote our MedinGel™, MedinCare™ and MedinHub™ systems based on synthetic biopolymers.
The aimed objective of this platform is to develop in real time customized formulations based on specific expected product specifications. This platform has been designed to perform first in vitro feasibility studies in average 1-2 months duration.
Main equipments of this platform include capillary electrophoresis, electron microscope, laser microscope spectrometer, HPLC, gel permeation chromatography, gas chromatography, U.V/visible spectrometer, viscoelasticimeter, automatic viscometer, rheometer, Coulter nanosizer, texturometer.
PHARMACOLOGY PLATFORMS, Lyon and Marseille, France
These platforms are specialized in pharmacological studies, performed in classical species such as mice, rats, ferrets, rabbits, cats, dogs, swine, horses, cattle, ovine and primates. Animal experimentations are carried out by veterinarians and experienced project leaders. Studies that can be performed include pK, pD, efficacy and safety tests, some of them being GLP accreditated. Large animal storage can be in cattleshed or in external grazing ground with place for stalling.
These platforms have been designed to perform first in vivo validations using our proprietary technologies MedinGel™, MedinCare™ and MedinHub™.
It has been also designed to work as a Contract Research Organization both for Animal Health and Human Health companies. To receive a quotation for your pharmacological studies, please send your query to business-development@medincell.eu.
